Mohammed F Aldawsari
Overview
Explore the profile of Mohammed F Aldawsari including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
72
Citations
499
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Omer A, Fatima F, Ahmed M, Aldawsari M, Alalaiwe A, Anwer M, et al.
Biomedicines
. 2023 Dec;
11(12).
PMID: 38137562
This study aimed to prepare glycyrrhizin-apigenin spray-dried solid dispersions and develop PVA filament-based 3D printlets to enhance the dissolution and therapeutic effects of apigenin (APN); three formulations (APN1-APN3) were proportioned...
12.
Aljuffali I, Anwer M, Ahmed M, Alalaiwe A, Aldawsari M, Fatima F, et al.
Pharmaceuticals (Basel)
. 2023 Nov;
16(11).
PMID: 38004415
In the current study, the toxic effects of gefitinib-loaded solid lipid nanoparticles (GFT-loaded SLNs) upon human breast cancer cell lines (MCF-7) were investigated. GFT-loaded SLNs were prepared through a single...
13.
Aldawsari M, Moglad E, Alotaibi H, Alkahtani H, Khafagy E
Polymers (Basel)
. 2023 Nov;
15(21).
PMID: 37960016
This study aimed at formulating the antiglaucoma agent, Bimatoprost (BMT), into niosomal in situ gel (BMT-ISG) for ocular delivery. Niosomes containing cholesterol/span 60 entrapping BMT were fabricated using a thin-film...
14.
Haque S, Hussain A, Almalki A, Aldawsari M, Lal B, Rai A, et al.
Cancer Metastasis Rev
. 2023 Nov;
43(2):621-637.
PMID: 37910294
Cancer is a major public health concern because it is one of the main causes of morbidity and mortality worldwide. As a result, numerous studies have reported the development of...
15.
Alkholifi F, Devi S, Aldawsari M, Foudah A, Alqarni M, Salkini M, et al.
Biomedicines
. 2023 Oct;
11(10).
PMID: 37893109
Researchers are actively exploring potential bioactive compounds to enhance the effectiveness of Lisuride (Lis) in treating Parkinson's disease (PD) over the long term, aiming to mitigate the serious side effects...
16.
Aldawsari M, Foudah A, Rawat P, Alam A, Salkini M
Gels
. 2023 Sep;
9(9).
PMID: 37754422
The emergence of antibiotic-resistant strains of () presents a substantial obstacle in medical environments. To effectively tackle this problem, we suggest an innovative approach: employing a delivery system based on...
17.
Aldawsari M, Khafagy E, Moglad E, Lila A
Saudi Pharm J
. 2023 Aug;
31(9):101734.
PMID: 37649675
Cetirizine hydrochloride (CTZ), a second-generation anti-histaminic drug, has been recently explored for its effectiveness in the treatment of alopecia. Niosomes are surfactant-based nanovesicular systems that have promising applications in both...
18.
Foudah A, Alam A, Ayman Salkini M, Ross S, Kumar P, Aldawsari M, et al.
Pharmaceuticals (Basel)
. 2023 Aug;
16(8).
PMID: 37631014
Breast cancer is a deadly disease that affects countless women worldwide. The most conventional treatments for breast cancer, such as the administration of anticancer medications such as letrozole (LTZ), pose...
19.
Aldawsari M, Alkholifi F, Foudah A, Alqarni M, Alam A, Salkini M, et al.
Pharmaceuticals (Basel)
. 2023 Aug;
16(8).
PMID: 37631005
The objective of this study was to develop an innovative gallic-acid (GA) drug delivery system that could be administered transdermally, resulting in enhanced therapeutic benefits and minimal negative consequences. The...
20.
Anwer M, Ahmed M, Aldawsari M, Iqbal M, Soliman G, Aljuffali I
Pharmaceutics
. 2023 May;
15(5).
PMID: 37242700
Eluxadoline (ELD), a recently approved drug, exhibits potential therapeutic effects in the management and treatment of IBS-D. However, its applications have been limited due to poor aqueous solubility, leading to...